Life sciences enthusiast; focused on CV/metabolics, diabetes, oncology, and the rest of biotech. Renown for my razor-sharp wit; someone you should know.
Track trial changes for FREE! Unlock the power of our proprietary clinical trial monitoring tool that seamlessly tracks updates from the website. Sign up at
Learn how the FREE web app can help you keep up with clinical trial updates. Be tech-ready for #ACOG2024# with to stay on top of trial changes. Visit our website now to start your stress-free trial monitoring journey.
Big news: The JNJ vaccine results of 44,000 Phase 3 trial, a single dose. Overall 66% efficacy, with the contrast of 72% in US but 57% in South Africa, confirming immune escape/resistance of B.1.351 variant seen by Novavax
$AMRN loses appeal, dashing its commercial hopes, @damiangarde writes.
A sure thing that suddenly needed a big test. A giant study many doubted would work, then did. The patent goes poof.
One of the strangest stories in biotech.
At 1 pm, @adamfeuerstein and will be doing a video chat regarding what we know about $GILD's remdesivir studies. STAT subscribers will receive a link to use to ask us questions. Anyone else will be able to watch from the STAT website.
Come!
.@HosseinBorghaei was celebrated today amongst friends and family @FoxChaseCancer as he became the inaugural Gloria and Edmund Dunn chair in Thoracic Oncology. I was honored to be invited to celebrate and humbled to call him my friend. Congratulations Hoss!
David DeJonghe from Lifescan Diabetes @LifescanDI showed at #ATTD2019# this interesting Rock Health data on digital health adoption across US age groups. Millennials will clearly be seeking more digital health than GenX. #wearenotwaiting# #doc#
Just broke the 38,000 mark on subscribers. Added 3,000+ this month alone. Want to break 40K by end of February. we'll be at 50K well before the end of the year. Fun! 3rd anniversary @endpts June 20.
I really enjoyed this anonymously authored @endpts piece about #JPM19#: May the candle burn forever: Polite reminders about the JPMorgan confab - @JohnCendpts@arsalanarif